Work

An Aliquoting Strategy for Commercial Gallium-68 Radiopharmaceutical Cold Kits.

Year: 2026

Type: article

Abstract: Ga colloids), indicating lower process robustness. Aliquoting reduced the theoretical radiopharmaceutical cost per patient dose by 38.6% for gozetotide and 35.7% for edotreotide. After accounting for the 26.0% edotreotide non-conformity rate in a replacement sensitivity analysis, the estimated edotreotide cost reduction remained 19.0%, and total annual savings at our institution were approximately 111,000 €. This kit-specific strategy can improve cold-kit utilization and reduce costs, but requires rigorous in-house validation and quality control.

Source: PubMed

DOI: 10.3791/74438

Authors: Jade Torchio, Marine M Cadet, Stéphane C Renaud, Léa Rubira, Cyril Fersing

Institutions: Institut Regional du Cancer de Montpellier, Université de Montpellier, Institut des Biomolécules Max Mousseron

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

Open Access status: green

OpenAlex ID: W7225232923

FWCI:

Cites:

Cited by:

Related to: 10